Submit Search
Upload
Acheson / Bode Food Safety Law 01-06-11
•
Download as PPT, PDF
•
0 likes
•
338 views
Leavitt Partners
Follow
Report
Share
Report
Share
1 of 31
Download now
Recommended
Learn about the new regulations under the U.S. FDA Food Safety Modernization Act (FSMA), including new requirements for U.S. Agents.
U.S. FDA Food Safety Modernization Act (FSMA) for Customs Brokers
U.S. FDA Food Safety Modernization Act (FSMA) for Customs Brokers
Registrar Corp
The U.S. FDA Food Safety Modernization Act (For Exporters To The Us)
The U.S. FDA Food Safety Modernization Act (For Exporters To The Us)
Registrar Corp
Food Modernization Act was signed into law on January 5th 2011. Related regulations are being written and will be enforced piece by piece. Companies will have between 2 to 4 years to complete implementation of required safety systems based on their operation size. This presentation shows what FSMA is about, who will be impacted and what the deadlines are for compliance.
Are you ready to implement FDA Food Safety Modernization Act?
Are you ready to implement FDA Food Safety Modernization Act?
Nikoo Arasteh
Drug facility pre-approval inspections are required to grant a complete response letter from the FDA to get a new drug application approved. FDA understands that some facilities which are located in regions impacted by COVID-19 may have some travel restrictions and cannot be inspected prior to granting such approval. In such situations FDA intends to continue using other tools and approaches such as requesting existing inspection reports from other trusted foreign regulatory partners through mutual recognition and confidentiality agreements as well as requesting records and other information directly from the facilities and other entities...
Drug Facility Pre-Inspections During the Pandemic
Drug Facility Pre-Inspections During the Pandemic
EMMAIntl
How FSMA Changes The Status Quo For Food Businesses
How FSMA Changes The Status Quo For Food Businesses
kmodza
If you have any questions or comments, please send them to connect@tracegains.com. We look forward to hearing from you. Can you handle the recent FSMA curveballs? The FDA made a big splash when it issued a set of “re-proposed” food safety regulations under the Food Safety Modernization Act (FSMA), including regulations for Current Good Manufacturing Practices (GMPs) and Hazard Analysis and Risk-Based Preventative Controls (HARPC) for Human Food. Two of the significant issues that the FDA is addressing are how product testing and supplier verification fit into FSMA’s requirement for food companies to verify that their preventative controls effectively and significantly minimize hazards at their facilities. This webinar will provide an overview of FDA’s comments on these two topics and insight about the legal issues they may raise for food companies. Further, the webinar will explore how the FDA expects you to implement FSMA, and what the FDA expects for firms to show they are in compliance.
Recent FSMA Updates and what the FDA Expects of You
Recent FSMA Updates and what the FDA Expects of You
TraceGains
Food Safety Modernization Act (FSMA) is placing new regulatory demands on food manufacturers and suppliers in the US market. For the first time, FDA has a legislative mandate to require comprehensive, prevention-based controls across the food supply. As key implementation deadlines approach, food manufacturers are shifting from a reactionary to a preventive footing, with stricter controls, documentation, and supplier verification requirements. This means there is a new regulatory world for food producers, including regulations for food-borne illness prevention and traceability. Presentation provides a summary of the new regulations, the risks and challenges faced by food producers, and the opportunities to take action through applications of modern control and information technology.
Food Safety Modernization Act (FSMA) regulatory requirements by FDA
Food Safety Modernization Act (FSMA) regulatory requirements by FDA
Brian Thomas
Presentation given at the 2011 Chinese Seafood and Fisheries Expo 2011, Qingdao China. "This seminar will provide an introduction to U.S. FDA Requirements and Procedures and the 2011 Food Safety Modernization Act for seafood exporters. Mr. Quinn is an attorney with expertise in FDA HACCP, food label reviews, FDA inspections and FDA import alerts." "此次研讨会将向水产品出口商详细介绍美国FDA的法律法规要求和 进口步骤，以及2011年食品安全现代化法案的相关政策。昆天佑 律师精通FDA 的HACCP体系合规性、食品标签审核、FDA检测及 FDA进口警示等领域"。 © 2011 http://www.fdaimports.com and http://www.exporttousa.com.cn
10 Steps To Import Seafood Into the United States From China 进口水产品到美国的十大步骤： F...
10 Steps To Import Seafood Into the United States From China 进口水产品到美国的十大步骤： F...
FDAimports.com
Recommended
Learn about the new regulations under the U.S. FDA Food Safety Modernization Act (FSMA), including new requirements for U.S. Agents.
U.S. FDA Food Safety Modernization Act (FSMA) for Customs Brokers
U.S. FDA Food Safety Modernization Act (FSMA) for Customs Brokers
Registrar Corp
The U.S. FDA Food Safety Modernization Act (For Exporters To The Us)
The U.S. FDA Food Safety Modernization Act (For Exporters To The Us)
Registrar Corp
Food Modernization Act was signed into law on January 5th 2011. Related regulations are being written and will be enforced piece by piece. Companies will have between 2 to 4 years to complete implementation of required safety systems based on their operation size. This presentation shows what FSMA is about, who will be impacted and what the deadlines are for compliance.
Are you ready to implement FDA Food Safety Modernization Act?
Are you ready to implement FDA Food Safety Modernization Act?
Nikoo Arasteh
Drug facility pre-approval inspections are required to grant a complete response letter from the FDA to get a new drug application approved. FDA understands that some facilities which are located in regions impacted by COVID-19 may have some travel restrictions and cannot be inspected prior to granting such approval. In such situations FDA intends to continue using other tools and approaches such as requesting existing inspection reports from other trusted foreign regulatory partners through mutual recognition and confidentiality agreements as well as requesting records and other information directly from the facilities and other entities...
Drug Facility Pre-Inspections During the Pandemic
Drug Facility Pre-Inspections During the Pandemic
EMMAIntl
How FSMA Changes The Status Quo For Food Businesses
How FSMA Changes The Status Quo For Food Businesses
kmodza
If you have any questions or comments, please send them to connect@tracegains.com. We look forward to hearing from you. Can you handle the recent FSMA curveballs? The FDA made a big splash when it issued a set of “re-proposed” food safety regulations under the Food Safety Modernization Act (FSMA), including regulations for Current Good Manufacturing Practices (GMPs) and Hazard Analysis and Risk-Based Preventative Controls (HARPC) for Human Food. Two of the significant issues that the FDA is addressing are how product testing and supplier verification fit into FSMA’s requirement for food companies to verify that their preventative controls effectively and significantly minimize hazards at their facilities. This webinar will provide an overview of FDA’s comments on these two topics and insight about the legal issues they may raise for food companies. Further, the webinar will explore how the FDA expects you to implement FSMA, and what the FDA expects for firms to show they are in compliance.
Recent FSMA Updates and what the FDA Expects of You
Recent FSMA Updates and what the FDA Expects of You
TraceGains
Food Safety Modernization Act (FSMA) is placing new regulatory demands on food manufacturers and suppliers in the US market. For the first time, FDA has a legislative mandate to require comprehensive, prevention-based controls across the food supply. As key implementation deadlines approach, food manufacturers are shifting from a reactionary to a preventive footing, with stricter controls, documentation, and supplier verification requirements. This means there is a new regulatory world for food producers, including regulations for food-borne illness prevention and traceability. Presentation provides a summary of the new regulations, the risks and challenges faced by food producers, and the opportunities to take action through applications of modern control and information technology.
Food Safety Modernization Act (FSMA) regulatory requirements by FDA
Food Safety Modernization Act (FSMA) regulatory requirements by FDA
Brian Thomas
Presentation given at the 2011 Chinese Seafood and Fisheries Expo 2011, Qingdao China. "This seminar will provide an introduction to U.S. FDA Requirements and Procedures and the 2011 Food Safety Modernization Act for seafood exporters. Mr. Quinn is an attorney with expertise in FDA HACCP, food label reviews, FDA inspections and FDA import alerts." "此次研讨会将向水产品出口商详细介绍美国FDA的法律法规要求和 进口步骤，以及2011年食品安全现代化法案的相关政策。昆天佑 律师精通FDA 的HACCP体系合规性、食品标签审核、FDA检测及 FDA进口警示等领域"。 © 2011 http://www.fdaimports.com and http://www.exporttousa.com.cn
10 Steps To Import Seafood Into the United States From China 进口水产品到美国的十大步骤： F...
10 Steps To Import Seafood Into the United States From China 进口水产品到美国的十大步骤： F...
FDAimports.com
FDA Globalization Act (Dingell Bill) Summary Jan 2009
FDA Globalization Act (Dingell Bill) Summary Jan 2009
phillipsm4
The presentation is about: Drug Regulatory Affairs as a profession, Scope & Responsibilities in life cycle management of a drug and role of RA in the drug approval process.
Regulatory Affairs Profession
Regulatory Affairs Profession
Institute of Pharmaceutical Management
PPT Development
PPT Development
Ashley Smithers, RGD
Kerr, Jason Final Poster
Kerr, Jason Final Poster
Jason Kerr, MBS, MBA
The presentation outlines how the TGA’s new priority review pathway for prescription medicines works and how medicines might be deemed to be a priority for Australian patients. We discuss how the provisional approval pathway contributes to early access and how to judge when early data seems promising.
Presentation: Updates from the Therapeutic Goods Administration - For medicin...
Presentation: Updates from the Therapeutic Goods Administration - For medicin...
TGA Australia
Regulatory affairs is a profession developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines.
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical Industry
Rama Shukla
Os arquivos das apresentações de eventos organizados pela AGROPEC são postados no SlideShare mediante autorização por escrito dos palestrantes.
Apresentação de Debra Edwards
Apresentação de Debra Edwards
Oxya Agro e Biociências
Dcgi adverse event
Dcgi adverse event
Prabir Chatterjee
It constitutes of basic introduction of regulatory affairs in pharmaceuticals, career in pharma regulatory affairs, job opportunities and future aspect. GIBTIndia offers job oriented e- learning courses. Kindly visit us at www.gibtindia.com
Introduction to Pharma regulatory affairs
Introduction to Pharma regulatory affairs
GIBT India
This presentation provides an overview of the TGA’s Food-Medicine Interface Guidance Tool (FMIGT) and the regulatory management of food-like products.
Regulatory and legal implications of food-like presentations
Regulatory and legal implications of food-like presentations
TGA Australia
An update on TGA experience with GMP clearances and an overview of the range of process improvements underway.
Presentation: GMP clearance requirements for medicines manufactured overseas
Presentation: GMP clearance requirements for medicines manufactured overseas
TGA Australia
Drug Regulatory Affairs Introduction
Drug Regulatory Affairs
Drug Regulatory Affairs
Namdeo Shinde
Presentation on Pharmacovigilance basics – sponsor obligations, Complementary medicine safety – Regulatory perspective and Special considerations for complementary medicine pharmacovigilance
Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
TGA Australia
FDA WARNING LETTER IS A OFFICIAL LETTER FROM USFDA TO A MANUFACTURING FIRM TO NOTICE THE SERIOUS VIOLATION FOUND AT THE FDA INSPECTION AT FIRM AND THE CORRECTIVE ACTION SHOULD TO TAKEN BY FIRM TO OVERCOME THE VIOLATION FOR FDA APPROVAL
FDA Warning letter
FDA Warning letter
Sridhar S
Please share this webinar with anyone who may be interested! Watch all our webinars: https://www.youtube.com/playlist?list=PL4dDQscmFYu_ezxuxnAE61hx4JlqAKXpR In this webinar: ● Primer for attendees attending the November 15-16 Drug Pricing Policy Summit ● Broad conceptual blueprint of federal and provincial/territorial public health policy structures across Canada ● Description of legal frameworks, government responsibility centres and their mandates for treatment access, with reference to specific opportunities for patient engagement View the video: https://youtu.be/X9AB70om-Dw Follow our social media accounts: Twitter - https://twitter.com/survivornetca Facebook - https://www.facebook.com/CanadianSurvivorNet Pinterest - https://www.pinterest.com/survivornetwork YouTube - https://www.youtube.com/user/Survivornetca
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
Canadian Cancer Survivor Network
Presentation regarding the quality use of medicines in Australia and enhancements to Australia’s medicines vigilance scheme.
GPs’ role in quality use of medicines in Australia
GPs’ role in quality use of medicines in Australia
TGA Australia
Principles & Content Outline Peter Pekos, CEO Dalton Pharma Services
Preparing an IND Application: CMC
Preparing an IND Application: CMC
Peter Pekos
Regulatory Affairs
Regulatory Affairs
ShabeenaZaidi
drug regulatory affaris
Drug regulatory affairs - 1
Drug regulatory affairs - 1
Tanuja Bisht
responsibilities, role and scope of DRA Professionals
Drug Regulatory Affairs- 2
Drug Regulatory Affairs- 2
Tanuja Bisht
AmCham Seminar
AmCham Seminar
Leavitt Partners
Acheson FSMA Tracing Webinar 01-07-11
Acheson FSMA Tracing Webinar 01-07-11
Leavitt Partners
More Related Content
What's hot
FDA Globalization Act (Dingell Bill) Summary Jan 2009
FDA Globalization Act (Dingell Bill) Summary Jan 2009
phillipsm4
The presentation is about: Drug Regulatory Affairs as a profession, Scope & Responsibilities in life cycle management of a drug and role of RA in the drug approval process.
Regulatory Affairs Profession
Regulatory Affairs Profession
Institute of Pharmaceutical Management
PPT Development
PPT Development
Ashley Smithers, RGD
Kerr, Jason Final Poster
Kerr, Jason Final Poster
Jason Kerr, MBS, MBA
The presentation outlines how the TGA’s new priority review pathway for prescription medicines works and how medicines might be deemed to be a priority for Australian patients. We discuss how the provisional approval pathway contributes to early access and how to judge when early data seems promising.
Presentation: Updates from the Therapeutic Goods Administration - For medicin...
Presentation: Updates from the Therapeutic Goods Administration - For medicin...
TGA Australia
Regulatory affairs is a profession developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines.
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical Industry
Rama Shukla
Os arquivos das apresentações de eventos organizados pela AGROPEC são postados no SlideShare mediante autorização por escrito dos palestrantes.
Apresentação de Debra Edwards
Apresentação de Debra Edwards
Oxya Agro e Biociências
Dcgi adverse event
Dcgi adverse event
Prabir Chatterjee
It constitutes of basic introduction of regulatory affairs in pharmaceuticals, career in pharma regulatory affairs, job opportunities and future aspect. GIBTIndia offers job oriented e- learning courses. Kindly visit us at www.gibtindia.com
Introduction to Pharma regulatory affairs
Introduction to Pharma regulatory affairs
GIBT India
This presentation provides an overview of the TGA’s Food-Medicine Interface Guidance Tool (FMIGT) and the regulatory management of food-like products.
Regulatory and legal implications of food-like presentations
Regulatory and legal implications of food-like presentations
TGA Australia
An update on TGA experience with GMP clearances and an overview of the range of process improvements underway.
Presentation: GMP clearance requirements for medicines manufactured overseas
Presentation: GMP clearance requirements for medicines manufactured overseas
TGA Australia
Drug Regulatory Affairs Introduction
Drug Regulatory Affairs
Drug Regulatory Affairs
Namdeo Shinde
Presentation on Pharmacovigilance basics – sponsor obligations, Complementary medicine safety – Regulatory perspective and Special considerations for complementary medicine pharmacovigilance
Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
TGA Australia
FDA WARNING LETTER IS A OFFICIAL LETTER FROM USFDA TO A MANUFACTURING FIRM TO NOTICE THE SERIOUS VIOLATION FOUND AT THE FDA INSPECTION AT FIRM AND THE CORRECTIVE ACTION SHOULD TO TAKEN BY FIRM TO OVERCOME THE VIOLATION FOR FDA APPROVAL
FDA Warning letter
FDA Warning letter
Sridhar S
Please share this webinar with anyone who may be interested! Watch all our webinars: https://www.youtube.com/playlist?list=PL4dDQscmFYu_ezxuxnAE61hx4JlqAKXpR In this webinar: ● Primer for attendees attending the November 15-16 Drug Pricing Policy Summit ● Broad conceptual blueprint of federal and provincial/territorial public health policy structures across Canada ● Description of legal frameworks, government responsibility centres and their mandates for treatment access, with reference to specific opportunities for patient engagement View the video: https://youtu.be/X9AB70om-Dw Follow our social media accounts: Twitter - https://twitter.com/survivornetca Facebook - https://www.facebook.com/CanadianSurvivorNet Pinterest - https://www.pinterest.com/survivornetwork YouTube - https://www.youtube.com/user/Survivornetca
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
Canadian Cancer Survivor Network
Presentation regarding the quality use of medicines in Australia and enhancements to Australia’s medicines vigilance scheme.
GPs’ role in quality use of medicines in Australia
GPs’ role in quality use of medicines in Australia
TGA Australia
Principles & Content Outline Peter Pekos, CEO Dalton Pharma Services
Preparing an IND Application: CMC
Preparing an IND Application: CMC
Peter Pekos
Regulatory Affairs
Regulatory Affairs
ShabeenaZaidi
drug regulatory affaris
Drug regulatory affairs - 1
Drug regulatory affairs - 1
Tanuja Bisht
responsibilities, role and scope of DRA Professionals
Drug Regulatory Affairs- 2
Drug Regulatory Affairs- 2
Tanuja Bisht
What's hot
(20)
FDA Globalization Act (Dingell Bill) Summary Jan 2009
FDA Globalization Act (Dingell Bill) Summary Jan 2009
Regulatory Affairs Profession
Regulatory Affairs Profession
PPT Development
PPT Development
Kerr, Jason Final Poster
Kerr, Jason Final Poster
Presentation: Updates from the Therapeutic Goods Administration - For medicin...
Presentation: Updates from the Therapeutic Goods Administration - For medicin...
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical Industry
Apresentação de Debra Edwards
Apresentação de Debra Edwards
Dcgi adverse event
Dcgi adverse event
Introduction to Pharma regulatory affairs
Introduction to Pharma regulatory affairs
Regulatory and legal implications of food-like presentations
Regulatory and legal implications of food-like presentations
Presentation: GMP clearance requirements for medicines manufactured overseas
Presentation: GMP clearance requirements for medicines manufactured overseas
Drug Regulatory Affairs
Drug Regulatory Affairs
Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
FDA Warning letter
FDA Warning letter
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
Drug Approval Bodies in Canada 101: The Elevator Length Pitch
GPs’ role in quality use of medicines in Australia
GPs’ role in quality use of medicines in Australia
Preparing an IND Application: CMC
Preparing an IND Application: CMC
Regulatory Affairs
Regulatory Affairs
Drug regulatory affairs - 1
Drug regulatory affairs - 1
Drug Regulatory Affairs- 2
Drug Regulatory Affairs- 2
Viewers also liked
AmCham Seminar
AmCham Seminar
Leavitt Partners
Acheson FSMA Tracing Webinar 01-07-11
Acheson FSMA Tracing Webinar 01-07-11
Leavitt Partners
Innovation
Innovation
Leavitt Partners
Aco whitepaper final
Aco whitepaper final
Leavitt Partners
Leavitt Partners’ Center for ACO Intelligence, which tracks national and regional trends related to ACOs and other emerging care delivery systems, released a white paper today entitled Growth and Dispersion of Accountable Care Organizations. This is the first report of its kind regarding the types and locations of ACOs. The report provides data-driven insights into the evolution of ACOs following federal health reform and the recent announcement of the Medicare Shared Savings Program. Data and analysis on the growth and national dispersion trends of more than 160 ACO or ACO-like organizations are highlighted.
Growth and Dispersion of Accountable Care Organizations
Growth and Dispersion of Accountable Care Organizations
Leavitt Partners
AmCham Seminar (In Mandarin)
AmCham Seminar (In Mandarin)
Leavitt Partners
The Leavitt Partners Center for ACO Intelligence, which tracks national and regional trends related to ACOs and other emerging care delivery systems, published a white paper entitled "Growth and Dispersion of Accountable Care Organizations." This is the first report of its kind regarding the types and locations of ACOs. The report provides data-driven insights into the evolution of ACOs following federal health reform and the recent announcement of the Medicare Shared Savings Program. Data and analysis on the growth and national dispersion trends of more than 160 ACO or ACO-like organizations are highlighted.
Growth and Dispersion of Accountable Care Organizations
Growth and Dispersion of Accountable Care Organizations
Leavitt Partners
Dr. David Muhlestein and Mathew Petersen, both of whom participate with Leavitt Partners' research on Accountable Care Organizations, co-authored the article ACO Results: What We Know So Far in Health Affairs Blog column on May 30th, 2014.
ACO Results: What We Know So Far
ACO Results: What We Know So Far
Leavitt Partners
Health Reform Bracketology is a scenario-planning tool that assesses the future of specific policies and provisions within the Patient Protection and Affordable Care Act. This assessment is conducted across a myriad of different political scenarios.
Health Reform Bracketology
Health Reform Bracketology
Leavitt Partners
Viewers also liked
(9)
AmCham Seminar
AmCham Seminar
Acheson FSMA Tracing Webinar 01-07-11
Acheson FSMA Tracing Webinar 01-07-11
Innovation
Innovation
Aco whitepaper final
Aco whitepaper final
Growth and Dispersion of Accountable Care Organizations
Growth and Dispersion of Accountable Care Organizations
AmCham Seminar (In Mandarin)
AmCham Seminar (In Mandarin)
Growth and Dispersion of Accountable Care Organizations
Growth and Dispersion of Accountable Care Organizations
ACO Results: What We Know So Far
ACO Results: What We Know So Far
Health Reform Bracketology
Health Reform Bracketology
Similar to Acheson / Bode Food Safety Law 01-06-11
David Acheson's Webinar Slides on Food Safety Legislation
David Acheson's Webinar Slides on Food Safety Legislation
Leavitt Partners
The first overhaul of the U.S. food manufacturing process in more than 80 years, the federal Food Safety Modernization Act (FSMA) law updates the role of the government in verifying the safety and availability of our food supply. FSMA, as it rolls out, has implications for both domestic manufacturers and those that distribute goods made abroad, in foreign facilities. The Food Institute analyzed the intersection of daily food production and regulatory compliance in this first in a series of 3 presentations on FSMA.
U.S. Food Safety Modernization Act: A Primer
U.S. Food Safety Modernization Act: A Primer
Lina Bush
by Jill Hollingsworth
Government Recognition of Third Party Certifications in the USA
Government Recognition of Third Party Certifications in the USA
SQF Institute
US FDA Regs & Modernization Act 2012
US FDA Regs & Modernization Act 2012
Asian Food Regulation Information Service
The Food Safety Modernization Act is the largest overhaul of the U.S. food processing system in more than 80 years. Thought it impacts domestic and foreign producers, there are quite a few changes in the new law important for Importers & foreign food manufacturers. Here is a highlight on how FSMA impacts Imported foods.
Food Safety Modernization Act: for importers
Food Safety Modernization Act: for importers
Lina Bush
Presented at the Conference section of Food & Hotel Singapore, 9 April 2014
US FDA Food Safety Modernization Act-Future Impact on Asia
US FDA Food Safety Modernization Act-Future Impact on Asia
Asian Food Regulation Information Service
FOOD SAFETY AND MODERNIZATION ACTsec 2
FOOD SAFETY AND MODERNIZATION ACTsec 2
Howard Schwenzer
December 15, 2010 webinar sponsored by The Weinberg Group on increased FDA enforcement activity under the Obama administration, with a focus on: Enforcement Trends Prior to Obama Administration Commissioner Hamburg Revives FDA’s Compliance Culture –The August 6, 2009 Speech and its Impact Key FDA Enforcement Actions How to Prepare for Increased Enforcement How to Respond if Targeted Consequences of Non-Compliance FDA’s Record under Enhanced Compliance
FDA Enforcement: The Cop is Back – How Enhanced Enforcement Can Impact You a...
FDA Enforcement: The Cop is Back – How Enhanced Enforcement Can Impact You a...
Michael Swit
fsma proposed rule on intentional adulteration
fsma proposed rule on intentional adulteration
ifmaworld
Drug facility pre-approval inspections are required to grant a complete response letter from the FDA to get a new drug application approved. FDA understands that some facilities which are located in regions impacted by COVID-19 may have some travel restrictions and cannot be inspected prior to granting such approval. In such situations FDA intends to continue using other tools and approaches such as requesting existing inspection reports from other trusted foreign regulatory partners through mutual recognition and confidentiality agreements as well as requesting records and other information directly from the facilities and other entities...
Drug Facility Pre-Inspections During the Pandemic
Drug Facility Pre-Inspections During the Pandemic
EMMAIntl
Regulatory Issues for Drugs, Devices, and Combination Products
Fda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science Industry
dmanalan
How to import natural and organic products to the United States. • Foods and Dietary Supplements • How FDA, USDA and Customs interact • Import Compliance • Import Alerts and FDA detentions • Organic and Natural claims • Food Safety Modernization Act Originally presented by Rick Quinn, Principal, at the 2012 Natural Products Expo Asia in Hong Kong. © 2012 FDAImports.com and ExportToUsa.com.cn http://www.fdaimports.com http://www.exporttousa.com.cn
How to Successfully Import Natural Products to the USA
How to Successfully Import Natural Products to the USA
FDAimports.com
David Glass presentation at 2019 AIChE FOODIE Conference, Philadelphia, PA, December 9, 2019.
David.Glass.FOODIE2019.Conference.presentation.12.09.19
David.Glass.FOODIE2019.Conference.presentation.12.09.19
David Glass
1.b alcances de la nueva ley de inocuidad de alimentos del fda
1.b alcances de la nueva ley de inocuidad de alimentos del fda
ProColombia
Presentation covers: Enforcement Trends Prior to Obama Administration Commissioner Hamburg Revives FDA’s Compliance Culture –The August 6, 2009 Speech and its Impact How to Prepare for Increased Enforcement How to Respond if Targeted Consequences of Non-Compliance
FDA Enforcement -- the Perils of Inadequate Compliance
FDA Enforcement -- the Perils of Inadequate Compliance
Michael Swit
Difference between NADA and ANDA
IPR NDA and ANDA
IPR NDA and ANDA
mahender Kotte
FDA's current deadline for publishing the final rules for preventative controls for is quickly approaching. Find out what your company needs to know to prepare for these new regulatory requirements for FDA-regulated processors. This presentation provides an overview of preventative controls requirements under the Food Safety Modernization Act (FSMA), what is HARPC, and how to make the HACCP to HARPC conversion, as well as reassessing food safety plans for compliance and effectiveness.
Preparing for New FSMA Preventive Controls Regulations
Preparing for New FSMA Preventive Controls Regulations
Alchemy Systems
Padgett and Becoat assignment for Excelsior College M6A1
Group4padgett&becoatm6a1
Group4padgett&becoatm6a1
Stephen Padgett
Vitamins and Dietary Supplements
Group4 padgett&becoatm6a1
Group4 padgett&becoatm6a1
Henry Becoat
Sma update
Sma update
complianceonline123
Similar to Acheson / Bode Food Safety Law 01-06-11
(20)
David Acheson's Webinar Slides on Food Safety Legislation
David Acheson's Webinar Slides on Food Safety Legislation
U.S. Food Safety Modernization Act: A Primer
U.S. Food Safety Modernization Act: A Primer
Government Recognition of Third Party Certifications in the USA
Government Recognition of Third Party Certifications in the USA
US FDA Regs & Modernization Act 2012
US FDA Regs & Modernization Act 2012
Food Safety Modernization Act: for importers
Food Safety Modernization Act: for importers
US FDA Food Safety Modernization Act-Future Impact on Asia
US FDA Food Safety Modernization Act-Future Impact on Asia
FOOD SAFETY AND MODERNIZATION ACTsec 2
FOOD SAFETY AND MODERNIZATION ACTsec 2
FDA Enforcement: The Cop is Back – How Enhanced Enforcement Can Impact You a...
FDA Enforcement: The Cop is Back – How Enhanced Enforcement Can Impact You a...
fsma proposed rule on intentional adulteration
fsma proposed rule on intentional adulteration
Drug Facility Pre-Inspections During the Pandemic
Drug Facility Pre-Inspections During the Pandemic
Fda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science Industry
How to Successfully Import Natural Products to the USA
How to Successfully Import Natural Products to the USA
David.Glass.FOODIE2019.Conference.presentation.12.09.19
David.Glass.FOODIE2019.Conference.presentation.12.09.19
1.b alcances de la nueva ley de inocuidad de alimentos del fda
1.b alcances de la nueva ley de inocuidad de alimentos del fda
FDA Enforcement -- the Perils of Inadequate Compliance
FDA Enforcement -- the Perils of Inadequate Compliance
IPR NDA and ANDA
IPR NDA and ANDA
Preparing for New FSMA Preventive Controls Regulations
Preparing for New FSMA Preventive Controls Regulations
Group4padgett&becoatm6a1
Group4padgett&becoatm6a1
Group4 padgett&becoatm6a1
Group4 padgett&becoatm6a1
Sma update
Sma update
More from Leavitt Partners
Value
Value
Leavitt Partners
Privacy and Mobilizing Health Data
Privacy and Mobilizing Health Data
Leavitt Partners
Pandemic
Pandemic
Leavitt Partners
Import Safety
Import Safety
Leavitt Partners
Michael O Leavitt: I call these speeches The Prologue Series. There is a statue behind the National Archives that I look at nearly every day as I drive between HHS and the White House. The statue, the work of Robert Aitken, is called “The Future.” It depicts a woman looking up to the horizon from a book as if to ponder what she has just read. At the base of the statue are the words from Shakespeare’s The Tempest “What is past is prologue.”
Health Diplomacy
Health Diplomacy
Leavitt Partners
Personalized Medicine
Personalized Medicine
Leavitt Partners
Health Reform Bracketology Oct 25
Health Reform Bracketology Oct 25
Leavitt Partners
Health Reform Bracketology Oct 18
Health Reform Bracketology Oct 18
Leavitt Partners
Health reform bracketology oct 7 [recovered]
Health reform bracketology oct 7 [recovered]
Leavitt Partners
Framework
Framework
Leavitt Partners
More from Leavitt Partners
(10)
Value
Value
Privacy and Mobilizing Health Data
Privacy and Mobilizing Health Data
Pandemic
Pandemic
Import Safety
Import Safety
Health Diplomacy
Health Diplomacy
Personalized Medicine
Personalized Medicine
Health Reform Bracketology Oct 25
Health Reform Bracketology Oct 25
Health Reform Bracketology Oct 18
Health Reform Bracketology Oct 18
Health reform bracketology oct 7 [recovered]
Health reform bracketology oct 7 [recovered]
Framework
Framework
Acheson / Bode Food Safety Law 01-06-11
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
Download now
![[object Object],[object Object]](https://image.slidesharecdn.com/foodsafetywebinarachesonbodefoodsafetylaw010611-110121102638-phpapp01/85/Acheson-Bode-Food-Safety-Law-01-06-11-1-320.jpg)
![[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)